Stock comparison
Genpact LTD is 1.9x more valuable than Astrana Health, Inc. by market capitalization ($4.98 B vs $2.56 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
G is larger
Genpact LTD is 1.9x more valuable than Astrana Health, Inc. by market capitalization ($4.98 B vs $2.56 B).
Market value leader
G
Genpact LTD is 1.9x more valuable than Astrana Health, Inc. by market capitalization ($4.98 B vs $2.56 B).
Revenue leader
G
G: $5.08B vs ASTH: $3.18B.
Profit leader
G
G: $552.49M vs ASTH: $24.00M.
Margin leader
G
G: 10.9% vs ASTH: 0.8% net margin.
| Metric | G | ASTH |
|---|---|---|
| Market cap | $4.98 B | $2.56 B |
| US-listed rank | #1421 | #1959 |
| Revenue (latest FY) | $5.08B | $3.18B |
| Net income (latest FY) | $552.49M | $24.00M |
| Net margin | 10.9% | 0.8% |
| P/E (trailing FY) | 9.0x | 106.5x |
| SEC filings | 1,502 | 1,003 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Genpact LTD is 1.9x more valuable than Astrana Health, Inc. by market capitalization ($4.98 B vs $2.56 B).
In their latest fiscal years, Genpact LTD reported $5.08B in revenue while Astrana Health, Inc. reported $3.18B.
Full pages: Genpact LTD and Astrana Health, Inc., or browse the full rankings.